USPTO serial 79292743
RD GLOBAL RESEARCH DEVELOPMENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SPARER, KATERINA DOROTHY
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RD GLOBAL RESEARCH DEVELOPMENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road, Suite 100Henderson, NV 89014UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely, surgical implants comprising artificial material, medical tubing, catheters, surgical devices and instruments used for the ablation of tissue, microwave ablation antenna, electrosurgical instruments, electrosurgical generators, pumps, electrodes, probes and monitors for use in medical procedures, laparoscopic instruments, laparoscopic devices for vessel sealing, laparoscopic devices for fusing tissue, laparoscopic devices for dividing tissue, apparatus, radiofrequency ablation catheters, endoscopic catheters, focal catheters, energy based ablation devices, diagnostic catheters, ducer sheaths and needles for use during electrophysiology procedures, cardiac cryoablation catheters, steerable sheaths for use during cryoablation procedures, electrosurgical devices for sealing soft tissue, medical devices for electrosurgical or electrocautery procedures for tissue cutting, tissue resectioning, hemostasis, and coagulation of blood vessels, cardiac pacing leads, temporary external catheters, ventricular assist devices, surgical ablation probes, medical device systems for use in renal denervation and other forms of neuromodulation of the sympathetic nervous system, comprised of catheters, generators and component parts and fittings therefor, guide wires, stents, stent grafts and stent delivery catheters, guide wires, stents, stent grafts and stent delivery catheters for use in intravascular, abdominal aorta aneurysm and peripheral procedures, endovascular fasteners and endovascular fastener appliers, endovascular guides, and endovascular catheters, each for use in the field of deploying, stabilizing, and securing of an endovascular prosthesis in a blood vessel for the treatment of an endovascular aneurysm, balloon catheters, surgical pencils, surgical sheaths, introducer sheaths, apparatus and instruments for blood transfusions, blood collection bags for medical purposes, cannula, oxygenators for medical use, cardiotomy reservoirs, venous reservoirs, blood collection reservoirs, venous air removal devices, arterial filters, centrifugal blood pumps, probe flow transducers for measuring blood flow, portable blood transfusion systems, heat exchangers for use in cardiopulmonary procedures for warming and cooling the blood, stainless steel heat exchanger tubes for use with medical apparatus and instruments, biocompatible surfaces for use on coronary bypass equipment, electrosurgical instruments used for hemostasis, coagulation, sealing of tissue and/or shrinkage of tissue, prosthetic heart valves and implantation instruments for heart valves, cardiac bioprosthesis, mechanical heart valves, aortic valved grafts, myocardial pacing leads, transcatheter heart valves and heart valve delivery catheters, transcatheter pulmonary valves, diagnostic catheters, guide catheters, drug-eluting stents, hemostatic pressure devices for closing wounds, crossing catheters, re-entry catheters, chronic total occlusion devices, coronary stents, directional atherectomy systems, arterial catheters and motor drive units to power arterial catheters, permanent metal prosthesis for the treatment of the obstructive coronary artery diseases, namely coronary stents and peripheral stents for obstructive peripheral diseases, embolic protection devices for the removal of debris during surgery, cerebral protection devices for the removal of debris during surgery, guidewires for surgical and medical purposes, valved infusion catheters, side hole infusion wires for use during thrombus treatments, expanding peripheral stents, biliary stents, balloon-expandable peripheral and biliary stents, renal stents, peripheral embolization products, vascular plugs, embolic devices, microcatheters, percutaneous transluminal angioplasty balloon catheters, snares for medical purposes, medical and surgical instruments, apparatus and devices for the treatment of varicose veins, support catheters, electronic apparatus and equipment for use in accessing, monitoring and programming implanted cardiac devices and diabetes infusion pumps, insulin infusion pumps and glucose monitors, programmable medication infusion pumps for delivery of medication, medical infusion sets, electric drive motors for medication infusion pumps, infusion tubing, infusion needles, needle guards, devices for use in medical diagnosis, screening and therapeutic applications, surgical devices used to insert and guide multiple needles through a tube for use in surgical procedures, medical devices for endoscopic ultrasound, ultrasonic infusion therapy, medical devices and surgical instruments, namely, radio frequency ablation devices consisting of energy generators, energy generator foot switches, output cables, ablation catheters, sizing balloons, hydrophobic filters, guidewires and endoscopic caps, all for use in the treatment of diseases of the esophagus, surgical devices and instruments used for the ablation of tissue using microwaves, surgical and medical apparatus, instruments and devices for use in general surgery, medical devices for the treatment of hemorrhoids, medical devices for the treatment of internal hemorrhoids, medical devices, namely, catheters comprising a pressure sensor for in-vivo pressure measurement, surgical mesh, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in repair, reinforcement or buttressing of soft tissue, prosthetic fabrics for parietal, visceral and vascular use, collagen-based membrane for neurological applications, neurological and orthopedic surgery components and implants made of titanium and alloys of titanium, meshes for use in bone reconstruction after cranial neurosurgical procedures, cranial robotics, laryngoscopes, apparatus, instruments and devices used for phototherapy, laser and UV light generators; artificial limbs, eyes and teeth; suture materials; massage apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 8, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 27, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 10, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 9, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 5, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 5, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 10, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 10, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 11, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |